Cargando…
SARS-CoV-2 antibody testing for transplant recipients: A tool to personalize protection versus COVID-19
Anti-spike antibody testing has emerged as a powerful tool to assess SARS-CoV-2 vaccine response in solid organ transplant (SOT) recipients, many of whom remain at risk for COVID-19 despite vaccination. Neither the US Food and Drug Administration nor major transplant societies recommend testing anti...
Autores principales: | Werbel, William A., Segev, Dorry L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111420/ https://www.ncbi.nlm.nih.gov/pubmed/35119179 http://dx.doi.org/10.1111/ajt.16993 |
Ejemplares similares
-
Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients
por: Boyarsky, Brian J., et al.
Publicado: (2021) -
Antibody response to a third dose of SARS‐CoV‐2 vaccine in heart and lung transplant recipients
por: Alejo, Jennifer L., et al.
Publicado: (2022) -
SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients
por: Hallett, Andrew M., et al.
Publicado: (2021) -
Antibody Response Six Months after SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease
por: Frey, Sarah, et al.
Publicado: (2022) -
Incident COVID-19 and Hospitalizations by Variant Era Among Vaccinated Solid Organ Transplant Recipients
por: Chiang, Teresa Po-Yu, et al.
Publicado: (2023)